Literature DB >> 24357874

Should dexmedetomidine replace benzodiazepines as the preferred sedative, as suggested by new guidelines from the society for critical care medicine?

.   

Abstract

Entities:  

Year:  2013        PMID： 24357874      PMCID： PMC3867569          DOI： 10.4212/cjhp.v66i6.1307

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  20 in total

1.  Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.

Authors:  Stephan M Jakob; Esko Ruokonen; R Michael Grounds; Toni Sarapohja; Chris Garratt; Stuart J Pocock; J Raymond Bratty; Jukka Takala
Journal:  JAMA       Date:  2012-03-21       Impact factor: 56.272

Review 2.  Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review.

Authors:  R Adams; G T Brown; M Davidson; E Fisher; J Mathisen; G Thomson; N R Webster
Journal:  Br J Anaesth       Date:  2013-06-07       Impact factor: 9.166

3.  A case-based approach to the practical application of dexmedetomidine in critically ill adults.

Authors:  Robert MacLaren; Jill C Krisl; Rebecca E Cochrane; Scott W Mueller
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

4.  The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation.

Authors:  M H Kollef; N T Levy; T S Ahrens; R Schaiff; D Prentice; G Sherman
Journal:  Chest       Date:  1998-08       Impact factor: 9.410

5.  Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.

Authors:  Richard R Riker; Yahya Shehabi; Paula M Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D Margolis; Daniel W Byrne; E Wesley Ely; Marcelo G Rocha
Journal:  JAMA       Date:  2009-02-02       Impact factor: 56.272

6.  Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Robert D Sanders; Timothy D Girard; Stuart McGrane; Jennifer L Thompson; Ayumi K Shintani; Daniel L Herr; Mervyn Maze; E Wesley Ely
Journal:  Crit Care       Date:  2010-03-16       Impact factor: 9.097

Review 7.  Role of dexmedetomidine in adults in the intensive care unit: an update.

Authors:  David P Reardon; Kevin E Anger; Christopher D Adams; Paul M Szumita
Journal:  Am J Health Syst Pharm       Date:  2013-05-01       Impact factor: 2.637

8.  Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Brenda T Pun; Daniel L Herr; Mervyn Maze; Timothy D Girard; Russell R Miller; Ayumi K Shintani; Jennifer L Thompson; James C Jackson; Stephen A Deppen; Renee A Stiles; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  JAMA       Date:  2007-12-12       Impact factor: 56.272

Review 9.  Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta-analysis of randomized clinical trials.

Authors:  Zhi-Qiu Xia; Shu-Qin Chen; Xi Yao; Chuan-Bo Xie; Shi-Hong Wen; Ke-Xuan Liu
Journal:  J Surg Res       Date:  2013-07-24       Impact factor: 2.192

Review 10.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

Authors:  Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.